Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...
MedPage Today on MSN
Myeloma combo with 'unprecedented' effect wins FDA approval
In second- or later-line setting, combination cut risk of disease progression or death by ...
C4 Therapeutics has dosed the first patient in its Phase II MOMENTUM trial of cemsidomide, an oral ikaros family zinc finger protein 1/3 (IKZF1/3) degrader, combined with dexamethasone for patients ...
Among patients with multiple myeloma (MM) undergoing autologous stem cell transplantation (ASCT), atrial fibrillation (AF) is a frequent and high-risk complication, according to a study published ...
For Julie Cohen, a diagnosis of multiple myeloma wasn't just a medical hurdle — it was a profound shift in perspective. Initially searching for a cure, she soon realized that navigating a high-risk, ...
Rich's Myeloma Story For Rich, what started as nagging back pain and fatigue became impossible to ignore. He'd always been active and on the move, so when the ...
Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...
In 2009, the IMF declared March as Myeloma Awareness Month. The program later evolved into Myeloma Action Month (MAM), which emphasizes individual and collective actions that positively impact the ...
Researchers have advanced DTP3, a first-in-class drug targeting the GADD45β/MKK7 complex, into Phase 2 trials for multiple ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson has received approval from the U ...
Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results